Therapeutic advances in non‐small cell lung cancer: Focus on clinical development of targeted therapy and immunotherapy

Cited by papers we hold 2

• Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance · 2022
  No notice
• Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials · 2022
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.